These compounds may interact with:
Dual specificity protein kinase CLK1
Potentially involved in: carcinoma; acute myeloid leukemia; acute quadriplegic myopathy; astrocytic glioma; dermatomyositis; ependymoma; glioblastoma; juvenile dermatomyositis; lung cancer; multiple myeloma; non-small cell lung cancer; osteosarcoma; ovarian cancer; pick disease; progressive supranuclear palsy; hamman-rich syndrome; pancreatic neuroendocrine tumor; gastrointestinal stromal tumor; renal cell carcinoma
Disease data sourced from Pharos.